Gilman Hill Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Gilman Hill Asset Management's IDXX Position: Q2 2026 in Review
Gilman Hill Asset Management reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $7.85K and leaving 618 shares worth $325K. The position accounts for 0.04% of the portfolio, ranked #185.
Gilman Hill Asset Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $428K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Gilman Hill Asset Management held 618 shares of Idexx Laboratories worth $325K as of Q2 2026.
- Gilman Hill Asset Management sold 14 Idexx Laboratories shares in Q2 2026, an estimated $7.85K.
- Idexx Laboratories made up 0.04% of Gilman Hill Asset Management's portfolio in Q2 2026, its #185 holding.
- Gilman Hill Asset Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
- Gilman Hill Asset Management's Idexx Laboratories position peaked at $428K in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.